Proteasomal cleavage of intracellular substrate (immunoproteasome catalyst)

Stable Identifier
R-HSA-9912655
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
ReviewStatus
3/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The ubiquitin (Ub)-dependent and Ub-independent proteasomal degradation is crucial for the turnover of damaged and regulatory proteins within cells. This mechanism also generates antigenic peptides that can be loaded on to class I major histocompatibility complex (MHC I) molecules and presented externally to cytotoxic CD8+ T lymphocytes (CTLs) (Mamrosh JL et al., 2023; reviewed by Embgenbroich M & Burgdorf S 2018; Admon A 2023).

This Reactome event shows Ub-independent antigen processing by immunoproteasome, a specialized form of the proteasome in which the standard catalytic subunits PSMB6 (β1), PSMB7 (β2), and PSMB5 (β5) of 20S core particle (CP) are replaced with PSMB9 (β1i), PSMB10 (β2i), and PSMB8 (β5i), respectively (Shin EC et al., 2006; Bai M et al., 2014; Santos R et al., 2017). This variation of the core particle is known as 20S iCP. Immunoproteasomes utilize the PA28 regulatory particle, a heteroheptamer of 4xPSME1:3xPSME2, to degrade substrates (Lesne J et al., 2020; Chen J et al., 2021). The catalytic and regulatory subunits of immunoproteasomes are constitutively expressed in various immune cells, such as T cells, B cells, and antigen-presenting cells (Inholz K et al., 2024; reviewed by McCarthy MK & Weinberg JB 2015). Their expression is also induced by pro-inflammatory cytokines such as interferon-gamma (IFNγ), type I interferons, and tumor necrosis factor alpha (TNF-α) in infected cells (Heink S et al. 2005; Niewerth D et al., 2014; reviewed by Kimura H et al. 2015; McCarthy MK & Weinberg JB 2015). While both standard catalytic β subunits of 20S CP and their immunoproteasome counterparts of 20S iCP exhibit caspase-like, trypsin-like, and chymotrypsin-like proteolytic activities, immunoproteasomes possess enhanced chymotrypsin- and trypsin-like activities, alongside with the reduced caspase-like activity (Cascio P et al., 2001; Kim S et al., 2022). These distinct enzymatic properties of immunoproteasomes generate C-terminal cleavage patterns that enhance loading of peptides onto MHC class I for immune presentation to killer T cells (reviewed in Tomko and Hochstrasser 2013). The peptides generated by the proteasome are either of the ideal length for binding to MHC class I molecules, ranging from 8 to 9 amino acids, or can be further cleaved by cytoplasmic aminopeptidases, including leucine aminopeptidase, puromycin-sensitive aminopeptidase, bleomycin hydrolase, and tripeptidyl peptidase II (Hearn A et al., 2010; Kim E et al., 2010). Within the endoplasmic reticulum (ER), extended peptides can be further trimmed by ER-resident aminopeptidases (ERAP1 and ERAP2) before being loaded onto MHC class I molecules (Rock KL et al., 2004; Saveanu L et al., 2005; Hearn A et al., 2010).

Literature References
PubMed ID Title Journal Year
15944226 IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response

Heink, S, Ludwig, D, Kloetzel, PM, Krüger, E

Proc Natl Acad Sci U S A 2005
35799704 Evaluation of Immunoproteasome-Specific Proteolytic Activity Using Fluorogenic Peptide Substrates

Kim, S, Park, SH, Choi, WH, Lee, MJ

Immune Netw 2022
11350924 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

Cascio, P, Hilton, C, Kisselev, AF, Rock, KL, Goldberg, AL

EMBO J 2001
38326304 Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing

Soh, WT, Roetschke, HP, Cormican, JA, Teo, BF, Chiam, NC, Raabe, M, Pflanz, R, Henneberg, F, Becker, S, Chari, A, Liu, H, Urlaub, H, Liepe, J, Mishto, M

Nat Commun 2024
16818754 Role of immunoproteasomes in cross-presentation

Palmowski, MJ, Gileadi, U, Salio, M, Gallimore, A, Millrain, M, James, E, Addey, C, Scott, D, Dyson, J, Simpson, E, Cerundolo, V

J Immunol 2006
Participants
Participates
Catalyst Activity

endopeptidase activity of Immunoproteasome [cytosol]

Orthologous Events
Authored
Created
Cite Us!